|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Continuing operations: | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Provision for expected credit loss on trade receivables and other receivables | |||||
| Allowance for expected credit losses on a related party receivable | |||||
| Impairment loss on goodwill | |||||
| Impairment loss on intangible assets | |||||
| Provision for withholding taxes receivable | |||||
| Provision for obsolete inventory | |||||
| Impairment loss on fixed assets | |||||
| Selling, distribution and administrative expenses | |||||
| Stock-based compensation expense | |||||
| Research and development expense | |||||
| Selling, general and administrative expenses | |||||
| Operating loss | |||||
| Other income, net | |||||
| Foreign exchange (losses)/gains, net | |||||
| Finance income/(costs), net | |||||
| Loss before income tax from continuing operations | |||||
| Provision for income tax benefit/(expense) | |||||
| Net loss for the year from continuing operations | |||||
| Discontinued operations: | |||||
| Net (loss)/profit for the year from discontinued operations | |||||
| Net loss for the year | |||||
| Net loss for the year attributable to: | |||||
| Net loss attributable to equity holders of the Company | |||||
| Net profit/(loss) attributable to non-controlling interests | |||||
| Basic loss attributable to the equity holders of the Company (in Dollars per share) | |||||
| Diluted loss attributable to the equity holders of the Company (in Dollars per share) | |||||
| Basic loss attributable to the equity holders of the Company from discontinued operations (in Dollars per share) | |||||
| Diluted loss attributable to the equity holders of the Company from discontinued operations (in Dollars per share) (in Dollars per share) | |||||
| Basic (in Shares) | |||||
| Diluted (in Shares) | |||||
Loading...